Fate Therapeutics Inc
FATE- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001434316
In the last 90 days, Fate Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 141 institutions reported holding it in 13F filings for Q3 2026, worth $169.0M in total; no superinvestor holds it.
13F holders, Q3 2026
Institutional positions in Fate Therapeutics Inc as of Sep 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 141
- −13 vs. Q2 2026
- Shares held
- 71.3M
- −233.2K (−0.3%) vs. Q2 2026
- Total value
- $169.0M
- −$24.1M (−12.5%) vs. Q2 2026
- New holders
- 17
- 32 more added
- Sold out
- 30
- 51 more reduced
3 institutions that held it in Q2 2026 haven't filed for Q3 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FATE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q3 2026 | 141 | $169.0M |
| Q2 2026 | 157 | $193.2M |
| Q1 2026 | 159 | $88.9M |
| Q4 2025 | 147 | $70.9M |
| Q3 2025 | 143 | $101.6M |
| Q2 2025 | 139 | $88.9M |
| Q1 2025 | 132 | $76.3M |
| Q4 2024 | 159 | $166.5M |
| Q3 2024 | 164 | $401.6M |
| Q2 2024 | 182 | $401.1M |
| Q1 2024 | 167 | $904.0M |
| Q4 2023 | 159 | $357.2M |
| Q3 2023 | 171 | $202.9M |
| Q2 2023 | 188 | $519.6M |
| Q1 2023 | 182 | $641.6M |
| Q4 2022 | 228 | $1.07B |
| Q3 2022 | 239 | $2.41B |
| Q2 2022 | 233 | $2.70B |
| Q1 2022 | 249 | $3.92B |
| Q4 2021 | 250 | $5.66B |
| Q3 2021 | 266 | $5.67B |
| Q2 2021 | 272 | $8.20B |
| Q1 2021 | 260 | $7.73B |
Institutions, Q3 2026
Shares, value and share of portfolio for each institution holding Fate Therapeutics Inc; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HSBC Holdings PLC | 162,802 | $395.6K | 0.00% | −77,922−32.4% | Reduced |
| UBS Group AG | 171,454 | $406.3K | 0.00% | −418,724−70.9% | Reduced |
| LPL Financial LLC | 172,746 | $409.4K | 0.00% | −31,000−15.2% | Reduced |
| Bridgeway Capital Management, LLC | 181,900 | $431.1K | 0.01% | −3,100−1.7% | Reduced |
| Empowered Funds, LLC | 181,900 | $431.1K | 0.00% | +181,900 | New |
| Point72 Asset Management, L.P. | 209,501 | $496.5K | 0.00% | −232,727−52.6% | Reduced |
| Schonfeld Strategic Advisors LLC | 231,659 | $549.0K | 0.00% | +165,501+250.2% | Added |
| Northern Trust Corp | 243,766 | $577.7K | 0.00% | +1,095+0.5% | Added |
| Cerity Partners LLC | 288,554 | $683.9K | 0.00% | −53,178−15.6% | Reduced |
| Invesco Ltd. | 294,342 | $697.6K | 0.00% | +28,360+10.7% | Added |
| Susquehanna Portfolio Strategies, LLC | 300,120 | $711.3K | 0.01% | −37,938−11.2% | Reduced |
| AQR Capital Management LLC | 352,086 | $834.4K | 0.00% | −3,485,143−90.8% | Reduced |
| Man Group plc | 368,205 | $872.6K | 0.00% | +192,098+109.1% | Added |
| Wellington Management Group LLP | 410,457 | $972.8K | 0.00% | +164,643+67.0% | Added |
| Privium Fund Management B.V. | 414,311 | $981.9K | 0.19% | 00.0% | Unchanged |
| Marshall Wace, LLP | 416,938 | $988.1K | 0.00% | −75,488−15.3% | Reduced |
| DAFNA Capital Management LLC | 500,000 | $1.19M | 0.25% | −25,000−4.8% | Reduced |
| Dimensional Fund Advisors LP | 517,313 | $1.23M | 0.00% | +165,087+46.9% | Added |
| State Street Corp | 602,128 | $1.43M | 0.00% | +43,200+7.7% | Added |
| Vanguard Fiduciary Trust Co | 640,428 | $1.52M | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 654,963 | $1.55M | 0.00% | +44,014+7.2% | Added |
| T. Rowe Price Investment Management, Inc. | 690,400 | $1.64M | 0.00% | −389,920−36.1% | Reduced |
| Morgan Stanley | 710,956 | $1.68M | 0.00% | +16,376+2.4% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 735,386 | $1.74M | 0.00% | +160,391+27.9% | Added |
| Citadel Advisors LLC | 846,920 | $2.01M | 0.00% | −146,388−14.7% | Reduced |
| Bruce & Co., Inc. | 989,188 | $2.34M | 0.64% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 1,311,765 | $3.11M | 0.00% | +1,165,927+799.5% | Added |
| Geode Capital Management, LLC | 1,320,456 | $3.13M | 0.00% | −1,557−0.1% | Reduced |
| Susquehanna International Group, LLP | 1,563,709 | $3.71M | 0.00% | +1,052,659+206.0% | Added |
| Qube Research & Technologies Ltd | 1,664,316 | $3.94M | 0.00% | +1,086,166+187.9% | Added |
| Goldman Sachs Group Inc | 2,061,740 | $4.89M | 0.00% | +12,553+0.6% | Added |
| Millennium Management LLC | 2,167,548 | $5.14M | 0.00% | −266,430−10.9% | Reduced |
| Arrowstreet Capital, Limited Partnership | 2,374,346 | $5.63M | 0.00% | +2,344,170+7,768.3% | Added |
| Renaissance Technologies LLC | 2,374,394 | $5.63M | 0.01% | −608,874−20.4% | Reduced |
| Johnson & Johnson | 3,379,064 | $8.01M | 1.05% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 3,905,357 | $9.26M | 0.01% | +315,494+8.8% | Added |
| Vanguard Capital Management LLC | 4,496,086 | $10.7M | 0.00% | +50,550+1.1% | Added |
| Acadian Asset Management LLC | 4,765,677 | $11.3M | 0.01% | +414,427+9.5% | Added |
| Vanguard Portfolio Management LLC | 4,959,037 | $11.8M | 0.00% | +413,144+9.1% | Added |
| BlackRock, Inc. | 7,105,172 | $16.8M | 0.00% | −193,723−2.7% | Reduced |
| Redmile Group, LLC | 12,872,946 | $30.5M | 2.23% | 00.0% | Unchanged |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −251,802−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −123,488−100.0% | Sold out |
| Mercer Global Advisors Inc | 0 | $0 | 0.00% | −113,380−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −34,105−100.0% | Sold out |
| Brighton Jones LLC | 0 | $0 | 0.00% | −33,271−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −29,002−100.0% | Sold out |
| Merit Financial Group, LLC | 0 | $0 | 0.00% | −26,367−100.0% | Sold out |
| Proficio Capital Partners LLC | 0 | $0 | 0.00% | −26,252−100.0% | Sold out |
| Pallas Capital Advisors LLC | 0 | $0 | 0.00% | −20,924−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −15,183−100.0% | Sold out |
| Krilogy Financial LLC | 0 | $0 | 0.00% | −14,873−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −14,584−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −13,413−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −13,322−100.0% | Sold out |
| Buckingham Strategic Partners | 0 | $0 | 0.00% | −12,033−100.0% | Sold out |
| NorthCrest Asset Manangement, LLC | 0 | $0 | 0.00% | −10,359−100.0% | Sold out |
| HB Wealth Management, LLC | 0 | $0 | 0.00% | −11,439−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −2,231−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −1,622−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −989−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −721−100.0% | Sold out |
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −670−100.0% | Sold out |
| Wealth Enhancement Trust Services, Inc. | 0 | $0 | 0.00% | −345−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −255−100.0% | Sold out |
| Basecamp Wealth Advisors LLC | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Providence Capital Advisors, LLC | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| JPL Wealth Management, LLC | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| SG Americas Securities, LLC | – | – | – | – | Not filed |
| Caerus Investment Advisors, LLC | – | – | – | – | Not filed |
| Royal Bank of Canada | – | – | – | – | Not filed |